Summit Therapeutics Inc. enters clinical collaboration to test ivonescimab with Datroway for breast cancer.
Oct 02, 2026
Contract Type
agreement
MiamiBiotechnologyHealth CareTherapeutics
Description
Summit Therapeutics Inc. has joined a three-company clinical collaboration to conduct a Phase III trial testing ivonescimab alongside Datroway. This partnership follows AstraZeneca's significant investment aimed at supporting combination studies.
Company Information
Company
Summit Therapeutics
Location
Miami, Florida, United States
About
Summit Therapeutics’ mission is to resolve serious, unmet medical needs for the betterment of overall human health.